(Q45100348)

9 December 2017

Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder (English)

1 reference

9 December 2017

Ji Youl Lee

1

1 reference

9 December 2017

Hyun Woo Kim

2

1 reference

9 December 2017

Seung Ju Lee

3

1 reference

9 December 2017

Jun Sung Koh

4

1 reference

9 December 2017

Hong Jin Suh

5

1 reference

9 December 2017

Michael B Chancellor

6

1 reference

9 December 2017

1 October 2004

1 reference

9 December 2017

1 reference

9 December 2017

94

1 reference

9 December 2017

6

1 reference

9 December 2017

817-820

1 reference

Prevalence of lower urinary tract symptoms in Austria as assessed by an open survey of 2,096 men.

9 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05039.X

A myogenic basis for the overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05039.X

Lower urinary tract symptoms, benign prostatic obstruction and the overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05039.X

Urodynamic and clinical effects of terazosin therapy in symptomatic patients with and without bladder outlet obstruction: a stratified analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05039.X

BPH with coexisting overactive bladder dysfunction--an everyday urological dilemma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05039.X

Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.05039.X

10.1111/J.1464-410X.2004.05039.X

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference